OPDC Team

Oxford Dementia Drug Discovery Institute (ODDI)

Professor Colin Akerman

Department of Pharmacology, University of Oxford

Dr Javier Alegre-Abarrategui

(Former OPDC Career Development Fellow), Institute of Neurology, London

Professor David Bannerman

Department of Experimental Psychology, University of Oxford

Professor Daniela Berg

Hertie Institute for Clinical Brain Research

Professor Chas Bountra

Nuffield Department of Medicine, Oxford / Structural Genomics Consortium (SGC)

Professor Ian Craddock

University of Bristol

Professor Jason Davis

Department of Chemistry, University of Oxford

The National Centre of Excellence in Research on Parkinson’s disease

Professor Matthew Farrer

Department of Medical Genetics, University of British Columbia

Professor Peter Flach

Faculty of Engineering, University of Bristol

Dr Donald Grosset

Institute of Neuroscience and Psychology, University of Glasgow / ProBAND

Dr Warren Hirst

Biogen Neurodegeneration Research Unit, Cambridge MA

Dr Kelvin Luk

Perelman School of Medicine, University of Pennsylvania

Dr Margaret May

Population Health Sciences, University of Bristol

Professor Paola Piccini

Centre of Neuroinflammation and Neurodegeneration, Imperial College, London

Professor Sir Peter Ratcliffe

Nuffield Department of Medicine / Target Discovery Institute (TDI), Oxford

JPND Research

EU Joint Programme – Neurodegenerative Disease Research

Professor Angela Russell

Department of Chemistry, University of Oxford

EU IMI StemBANCC Consortium

Professor Georg Terstappen

AbbVie Pharmaceuticals / StemBANCC

ProBAND Tracking Parkinson's

No Tremor

Virtual, Physiological and Computational Neuromuscular Models for the ...

Dementias Platform UK